Prevalence of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis: Correlation with Physiological Parameters

被引:28
|
作者
Papakosta, D. [1 ]
Pitsiou, G. [1 ]
Daniil, Z. [2 ]
Dimadi, M. [3 ]
Stagaki, E. [4 ]
Rapti, A. [5 ]
Antoniou, K. [6 ]
Tzouvelekis, A. [7 ]
Kontakiotis, T. [1 ]
Tryfon, S. [8 ]
Polychronopoulos, V. [4 ]
Bouros, D. [7 ]
机构
[1] Aristotle Univ Thessaloniki, G Papanikolaou Hosp, Dept Pneumonol, Thessaloniki 57010, Greece
[2] Univ Thessaly, Dept Pneumonol, Larisa, Greece
[3] SOTIRIA Athens Chest Hosp, Dept Pneumonol 1, Athens, Greece
[4] Sismanogl Gen Dist Hosp, Dept Pneumonol 3, Athens, Greece
[5] SOTIRIA Athens Chest Hosp, Dept Pneumonol 8, Athens, Greece
[6] Univ Crete, Dept Pneumonol, Iraklion, Greece
[7] Democritus Univ Thrace, Dept Pneumonol, Alexandroupolis, Greece
[8] G Papanikolaou Hosp, Dept Pneumonol 1, Thessaloniki, Greece
关键词
Pulmonary hypertension; Idiopathic pulmonary fibrosis; Diffusing capacity of the lung for carbon monoxide; Alveolar-arterial oxygen gradient; 6-min walk distance; Resting room air pulse oximetry; BRAIN NATRIURETIC PEPTIDE; LUNG-DISEASE; DOPPLER-ECHOCARDIOGRAPHY; EXERCISE CAPACITY; SURVIVAL; PRESSURE;
D O I
10.1007/s00408-011-9304-5
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The aim of this study was to prospectively evaluate the prevalence of pulmonary hypertension (PH) in patients with idiopathic pulmonary fibrosis (IPF). One hundred thirty-nine patients (101 male, mean age = 68.6 +/- A 9 years), with confirmed IPF and who were admitted to eight Pulmonary Departments in Greece between November 2005 and December 2006 were included in the study. Pulmonary artery systolic pressure (PASP) was estimated by echocardiography, and PH was defined as PASP > 36 mmHg. We compared demographics, pulmonary function tests, NYHA functional status, 6-min walk distance (6MWD), B-type natriuretic peptide (BNP), PaO2, and P(A-a)O-2 at rest data between patients with PH and without PH (PASP a parts per thousand currency sign 36 mmHg). Increased estimated right ventricular systolic pressure was present in 55% of patients (mean PASP = 47.1 +/- A 11.2 mmHg vs. 30.3 +/- A 3.8 mmHg, respectively). Patients with PH had a lower but not statistically significant DLCO (47.1 +/- A 18.8 vs. 52.5 +/- A 20.1), lower PaO2 at rest (64.6 +/- A 12.2 vs. 71.1 +/- A 11.3, P = 0.004), and lower mean 6MWD (282 +/- A 118 vs. 338 +/- A 91, P = 0.007). Significant differences were also observed in the NYHA functional status between the two groups (P = 0.02). Statistically significant correlations were observed between PASP and PaO2 at rest (r = -0.331, P = 0.00), P(A-a)O-2 at rest (r = 0.494, P = 0.00)(,) 6MWD (r = -0.264, P = 0.01), SpO(2) at rest (r = -0.293, P = 0.00), SpO(2) at the end of exercise (r = -0.364, P = 0.00), and also BNP values (r = 0.319, P = 0.01). Moreover, PaO2 (P = 0.02), P(A-a)O-2 (P = 0.005), and SpO(2) at the end of exercise (P = 0.023) were independent predictors of the presence of estimated PH. Using Doppler echocardiography as a screening tool for the estimation of PH, we found that PH is common in patients with IPF. Gas exchange parameters at rest and exercise desaturation might indicate underlying PH in IPF.
引用
收藏
页码:391 / 399
页数:9
相关论文
共 50 条
  • [1] Prevalence of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis: Correlation with Physiological Parameters
    D. Papakosta
    G. Pitsiou
    Z. Daniil
    M. Dimadi
    E. Stagaki
    A. Rapti
    K. Antoniou
    A. Tzouvelekis
    T. Kontakiotis
    S. Tryfon
    V. Polychronopoulos
    D. Bouros
    Lung, 2011, 189 : 391 - 399
  • [2] Pulmonary hypertension in patients with idiopathic pulmonary fibrosis
    Nadrous, HF
    Pellikka, PA
    Krowka, MJ
    Swanson, KL
    Chaowalit, N
    Decker, P
    Ryu, JH
    CHEST, 2004, 126 (04) : 771S - 771S
  • [3] Pulmonary hypertension in patients with idiopathic pulmonary fibrosis
    Nadrous, HF
    Pellikka, PA
    Krowka, MJ
    Swanson, KL
    Chaowalit, N
    Decker, PA
    Ryu, JH
    CHEST, 2005, 128 (04) : 2393 - 2399
  • [4] Prevalence of Pulmonary Arterial Hypertension (PAH) in Patients With Idiopathic Pulmonary Fibrosis (IPF)
    Villar, Adolfo
    Ancochea, Julio
    Xaubet, Antonio
    CHEST, 2014, 145 (03)
  • [5] PULMONARY HYPERTENSION IN IDIOPATHIC PULMONARY FIBROSIS: PREVALENCE AND CLINICAL PROGRESS
    Castria, D.
    Refini, R. M.
    Bargagli, E.
    Mezzasalma, F.
    Pierli, C.
    Rottoli, P.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2012, 25 (03) : 681 - 689
  • [6] OUTCOMES IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS AND PULMONARY HYPERTENSION
    Collins, Ashley
    King, Christopher
    Shlobin, Oksana
    Nathan, Steven
    CHEST, 2020, 158 (04) : 1071A - 1072A
  • [7] Correlation of pulmonary function and sleep disordered breathing parameters in patients with idiopathic pulmonary fibrosis
    Mermigkis, Charalampos
    Bouloukaki, Izolde
    Antoniou, Katerina
    Giannarakis, Giannis
    Mauroudi, Helen
    Moniaki, Violeta
    Siafakas, Nikolaos
    Schiza, Sophia
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [8] Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis
    Lettieri, CJ
    Nathan, SD
    Barnett, SD
    Ahmad, S
    Shorr, AF
    CHEST, 2006, 129 (03) : 746 - 752
  • [9] Pulmonary hypertension in idiopathic pulmonary fibrosis
    Amany Omar Mohammed
    Azza Farag Said El-Tooney
    Nasser Mohammed Taha
    Hosny Sayed Abdel Ghani
    Zainab Hassan Saied
    Egyptian Journal of Bronchology, 2014, 8 (1) : 23 - 31
  • [10] Pulmonary hypertension in idiopathic pulmonary fibrosis
    Patel, Nina M.
    Lederer, David J.
    Borczuk, Alain C.
    Kawut, Steven M.
    CHEST, 2007, 132 (03) : 998 - 1006